Recombinant multi-species GIPC3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GIPC3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the GIPC family. Studies in mice suggest that this gene is required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion in the ear. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2011]
The Alternative Names of target: Ahl5,C19orf64,DFNB15,DFNB72,DFNB95,GIPC3,Gipc3,PDZ domain-containing protein GIPC3,RGD1563255,Rgs19ip3

Target products collectionGo to GIPC3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP5202-Ag-1/ GM-Tg-hg-IP5202-Ag-2 Human GIPC3 protein Human
GM-Tg-rg-IP5202-Ag-1/ GM-Tg-rg-IP5202-Ag-2 Rat GIPC3 protein Rat
GM-Tg-mg-IP5202-Ag-1/ GM-Tg-mg-IP5202-Ag-2 Mouse GIPC3 protein Mouse
GM-Tg-cynog-IP5202-Ag-1/ GM-Tg-cynog-IP5202-Ag-2 Cynomolgus/Rhesus macaque GIPC3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP5202-Ag-1/ GM-Tg-felg-IP5202-Ag-2 Feline GIPC3 protein Feline
GM-Tg-cang-IP5202-Ag-1/ GM-Tg-cang-IP5202-Ag-2 Canine GIPC3 protein Canine
GM-Tg-bovg-IP5202-Ag-1/ GM-Tg-bovg-IP5202-Ag-2 Bovine GIPC3 protein Bovine
GM-Tg-equg-IP5202-Ag-1/ GM-Tg-equg-IP5202-Ag-2 Equine GIPC3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP5202-Ag-1/ GM-Tg-hg-IP5202-Ag-2; GM-Tg-rg-IP5202-Ag-1/ GM-Tg-rg-IP5202-Ag-2;
GM-Tg-mg-IP5202-Ag-1/ GM-Tg-mg-IP5202-Ag-2; GM-Tg-cynog-IP5202-Ag-1/ GM-Tg-cynog-IP5202-Ag-2;
GM-Tg-felg-IP5202-Ag-1/ GM-Tg-felg-IP5202-Ag-2; GM-Tg-cang-IP5202-Ag-1/ GM-Tg-cang-IP5202-Ag-2;
GM-Tg-bovg-IP5202-Ag-1/ GM-Tg-bovg-IP5202-Ag-2; GM-Tg-equg-IP5202-Ag-1/ GM-Tg-equg-IP5202-Ag-2
Products Name GIPC3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name GIPC3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GIPC3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.